Aspiriant LLC’s Schwab Fundamental US Large Company Index ETF FNDX Stock Holding History

Aspiriant LLC’s Portfolio FNDX Stock Details FNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Hold	8,199	–	–	0.01%	342
2026 Q1	$228K	Hold	8,199	–	–	0.01%	316
2025 Q4	$223K	Hold	8,199	–	–	0.01%	309
2025 Q3	$216K	Sell	8,199 -783	-9%	-$19.9K	0.01%	288
2025 Q2	$220K	Hold	8,982	–	–	0.01%	293
2025 Q1	$212K	Hold	8,982	–	–	0.01%	281
2024 Q4	$213K	Hold	8,982	–	–	0.01%	278
2024 Q3	$215K	Buy	+8,982	New	+$207K	0.01%	272
2018 Q4	–	Sell	-18,525	Closed	-$245K	–	235
2018 Q3	$245K	Hold	18,525	–	–	0.02%	212
2018 Q2	$231K	Sell	18,525 -10,860	-37%	-$135K	0.02%	227
2018 Q1	$356K	Buy	+29,385	New	+$370K	0.03%	176

Other funds holding FNDX

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

McAdam LLC Philadelphia, Pennsylvania $2.59B AUM 21.24% 1-Year Est. Return

BFA

Boulay Financial Advisors Eden Prairie, Minnesota $1.08B AUM 23.64% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

SCM

Steele Capital Management Dubuque, Iowa $2.72B AUM 21.58% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Aspiriant LLC's FNDX Position: Q2 2026 in Review

Aspiriant LLC held its Schwab Fundamental US Large Company Index ETF (FNDX) position steady in Q2 2026 at 8,199 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #342.

Aspiriant LLC first reported a position in FNDX in Q1 2018 and has held it in 11 quarters since. The position peaked at $356K in Q1 2018. 839 funds tracked by Wall St. Rank hold FNDX as of Q2 2026.

Aspiriant LLC held 8,199 shares of Schwab Fundamental US Large Company Index ETF worth $255K as of Q2 2026.
Aspiriant LLC left its Schwab Fundamental US Large Company Index ETF share count unchanged in Q2 2026.
Schwab Fundamental US Large Company Index ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #342 holding.
Aspiriant LLC first reported a position in Schwab Fundamental US Large Company Index ETF in Q1 2018 and has held it in 11 quarters since.
Aspiriant LLC's Schwab Fundamental US Large Company Index ETF position peaked at $356K in Q1 2018.
839 funds tracked by Wall St. Rank held Schwab Fundamental US Large Company Index ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.